Abcam Plc (LON:ABC)‘s stock had its “hold” rating reissued by Stifel Nicolaus in a report released on Monday, Analyst Ratings Net reports.

ABC has been the subject of a number of other reports. Peel Hunt reaffirmed a “buy” rating and issued a GBX 660 ($9.42) price objective on shares of Abcam Plc in a research note on Wednesday, November 11th. JPMorgan Chase & Co. increased their price target on shares of Abcam Plc from GBX 506 ($7.22) to GBX 558 ($7.96) and gave the company a “neutral” rating in a research report on Thursday, November 5th. Canaccord Genuity raised shares of Abcam Plc to a “hold” rating and set a GBX 432 ($6.16) price target for the company in a research report on Monday, November 2nd. Finally, Numis Securities Ltd lowered shares of Abcam Plc to an “add” rating and set a GBX 700 ($9.99) price target for the company. in a research report on Monday. One research analyst has rated the stock with a sell rating, four have given a hold rating and two have issued a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus price target of GBX 534.86 ($7.63).

In related news, insider Hirzel,Alan Thomas acquired 3,335 shares of the business’s stock in a transaction dated Wednesday, November 11th. The shares were purchased at an average price of GBX 580 ($8.28) per share, for a total transaction of £19,343 ($27,597.37). Also, insider Iliffe,Jeffrey acquired 301 shares of the business’s stock in a transaction dated Tuesday, October 27th. The shares were bought at an average price of GBX 599 ($8.55) per share, for a total transaction of £1,802.99 ($2,572.39).

Abcam Plc (LON:ABC) opened at 644.0000 on Monday. The company has a 50 day moving average of GBX 620.74 and a 200-day moving average of GBX 587.88. The stock’s market cap is GBX 1.29 billion. Abcam Plc has a 12-month low of GBX 260.50 and a 12-month high of GBX 674.00.

Abcam plc is a producer and distributor of antibodies and associated protein research products. The Company develops and manufactures its own products, as well as externally sourcing products. The Company’s product includes Primary antibodies, including RabMAbs (LON:ABC), Secondary antibodies, Functional assays, ELISA and other kits, Biochemicals, Isotype controls, Flow cytometry multi-color selector, Kits, Loading controls, Lysates, Peptides, Proteins, Slides, Tags and cell markers and Tools and Reagents. The Company’s subsidiaries include Abcam Inc, Abcam KK, Abcam (Hong Kong) Limited, Ascent Scientific Limited, Epitomics Inc, Epitomics (Hangzhou) Biotechnology Co. Limited and MitoSciences Inc

Receive News & Ratings for Abcam Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abcam Plc and related companies with MarketBeat.com's FREE daily email newsletter.